HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Response of Egyptian infants with protein calorie malnutrition to hepatitis B vaccination.

Abstract
The response to recombinant hepatitis B vaccine was assessed in 31 seronegative infants (2-26 months old) with protein calorie malnutrition (PCM), compared with 13 seronegative age- and sex-matched healthy infants. Both groups received three 10 micrograms vaccine doses at 0, 1, and 6 months. At month 8, all healthy infants and 87 per cent (27 out of 31) of PCM infants were seroprotected. Thus, hepatitis B vaccination (Engerix-B, SmithKline Beecham Biologicals) can be used effectively in PCM for mass vaccination in developing communities.
AuthorsY el-Gamal, R H Aly, E Hossny, E Afify, D el-Taliawy
JournalJournal of tropical pediatrics (J Trop Pediatr) Vol. 42 Issue 3 Pg. 144-5 (06 1996) ISSN: 0142-6338 [Print] England
PMID8699579 (Publication Type: Journal Article)
Chemical References
  • Hepatitis B Antibodies
  • Hepatitis B Vaccines
Topics
  • Child, Preschool
  • Developing Countries
  • Egypt
  • Female
  • Hepatitis B (immunology, prevention & control)
  • Hepatitis B Antibodies (biosynthesis)
  • Hepatitis B Vaccines (administration & dosage, immunology)
  • Humans
  • Immunization Schedule
  • Infant
  • Male
  • Protein-Energy Malnutrition (immunology)
  • Vaccination

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: